DOCSLIB.ORG

ELISA Kit 48T/96T SG-00

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ELISA Kit 48T/96T SG-00 ÜRÜN KOD ÜRÜN ADI KUTU SG-00001 Bovine Brucella ELISA Kit 48T/96T SG-00002 Human 8-Isoprostane(8-ISO)ELISA Kit 48T/96T SG-00003 Human adrencocorticotropic hormone(ACTH)ELISA Kit 48T/96T SG-00004 Human Carnitine palmityltransferase 1A(CPT1A)ELISA Kit 48T/96T SG-00005 Human hepatitis C virus(HCV) antibody(IgM)ELISA Kit 48T/96T SG-00006 Human Hyaluronan-binding protein(HABP)ELISA Kit 48T/96T SG-00007 Human monocyte chemotactic protein 1(MCP-1)ELISA Kit 48T/96T SG-00008 Human Proinsulin(PI)ELISA Kit 48T/96T SG-00009 Human urotensin II(UII)ELISA Kit 48T/96T SG-00010 Rat Leptospira IgG ELISA Kit 48T/96T SG-00011 Human cystathionine β-synthase(CBS) ELISA Kit 48T/96T SG-00012 Rat heart fatty acid binding protein,h-FABP ELISA Kit 48T/96T SG-00013 Rat Liver Type Fatty Acid Binding Protein(L-FABP) ELISA KIT 48T/96T SG-00014 Sheep thyroxine (T4) ELISA kit 48T/96T SG-00015 Aflatoxin B1 ELISA Kit 48T/96T SG-00016 Aflatoxin M1 ELISA Kit 48T/96T SG-00017 Bovien Non-esterified fatty acid(NEFA)ELISA Kit 48T/96T SG-00018 Bovine Activin A(ACV) ELISA Kit 48T/96T SG-00019 Bovine 1,25-Dihydroxyvitamin D3(1,25 DHVD3) ELISA kit 48T/96T SG-00020 Bovine 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) (HMGCS2) 48T/96T SG-00021 Bovine 6-phosphofructokinase, liver type(PFKL) ELISA kit 48T/96T SG-00022 Bovine 72 kDa type IV collagenase(MMP2) ELISA kit 48T/96T SG-00023 Bovine 8-Hydroxydeoxyguanosine (8-OHdG) ELISA kit 48T/96T SG-00024 Bovine A disintegrin and metalloproteinase with thrombospondin motifs 2(ADAMTS2) ELISA kit 48T/96T SG-00025 Bovine A disintegrin and metalloproteinase with thrombospondin motifs 4(ADAMTS4) ELISA kit 48T/96T SG-00026 Bovine A disintegrin and metalloproteinase with thrombospondin motifs 5(ADAMTS5) ELISA kit 48T/96T SG-00027 Bovine Acetylcholinesterase(ACHE) ELISA kit 48T/96T SG-00028 Bovine activated protein C (APC) ELISA kit 48T/96T SG-00029 Bovine Activin A,ACV-A ELISA Kit 48T/96T SG-00030 Bovine Acyl-CoA desaturase(SCD) ELISA kit 48T/96T SG-00031 Bovine Adenosine deaminase(ADA) ELISA kit 48T/96T SG-00032 Bovine adenovirus(ADV) elisa kit 48T/96T SG-00033 Bovine adiponectin(ADP) ELISA Kit 48T/96T SG-00034 Bovine adrenocorticotropic hormone (ACTH) ELISA kit 48T/96T SG-00035 Bovine adrenomedullin (ADM) ELISA kit 48T/96T SG-00036 Bovine adrenomedullin,ADM ELISA Kit 48T/96T SG-00037 Bovine Agouti-signaling protein(ASIP) ELISA kit 48T/96T SG-00038 Bovine Alpha-1-antitrypsin(SERPINA1) ELISA kit 48T/96T SG-00039 Bovine Alpha-1B-glycoprotein(A1BG) ELISA kit 48T/96T SG-00040 Bovine alpha-1-microglobulin/bikunin precursor (AMBP) ELISA kit 48T/96T SG-00041 Bovine Alpha-2-HS-glycoprotein(AHSG) ELISA kit 48T/96T SG-00042 Bovine Alpha-2-macroglobulin(A2M) ELISA kit 48T/96T SG-00043 Bovine Angiopoietin-1(ANGPT1) ELISA kit 48T/96T SG-00044 Bovine Angiopoietin-related protein 4(ANGPTL4) ELISA kit 48T/96T SG-00045 Bovine anti respiratory syncytial virus (RSV) antibody (IgG)ELISA kit 48T/96T SG-00046 Bovine anti-Mullerian hormone (AMH) ELISA kit 48T/96T SG-00047 Bovine anti-toxoplasmosis (TOXO) antibody (IgG) ELISA kit 48T/96T SG-00048 Bovine Apolipoprotein A-I(APOA1) ELISA kit 48T/96T SG-00049 Bovine Apolipoprotein A-I-binding protein(APOA1BP) ELISA kit 48T/96T SG-00050 Bovine Apolipoprotein A-IV(APOA4) ELISA kit 48T/96T SG-00051 Bovine Apolipoprotein B (APOB) ELISA kit 48T/96T SG-00052 Bovine Apolipoprotein E(APOE) ELISA kit 48T/96T SG-00053 Bovine Apolipoprotein O(APOO) ELISA kit 48T/96T SG-00054 Bovine Appetite-regulating hormone(GHRL) ELISA kit 48T/96T SG-00055 Bovine arachidonic Acid(AA) ELISA kit 48T/96T SG-00056 Bovine Beta-1,4-galactosyltransferase 1(B4GALT1) ELISA kit 48T/96T SG-00057 Bovine Beta-2-glycoprotein 1(APOH) ELISA kit 48T/96T SG-00058 Bovine Beta-casein(CSN2) ELISA kit 48T/96T SG-00059 Bovine Beta-defensin 1(DEFB1) ELISA kit 48T/96T SG-00060 Bovine Beta-defensin 119(DEFB119) ELISA kit 48T/96T SG-00061 Bovine Beta-Endorphin(β-EP) ELISA Kit 48T/96T SG-00062 Bovine Beta-galactosidase(GLB1) ELISA kit 48T/96T SG-00063 Bovine Beta-Hydroxybutyric Acid(β-OHB) ELISA Kit 48T/96T SG-00064 Bovine beta-lactoglobulin (Beta-LG) (allergen Bos d 5) (LGB)ELISA kit 48T/96T SG-00065 Bovine Beta-nerve growth factor(NGF) ELISA kit 48T/96T SG-00066 Bovine Blood urea nitrogen(BUN) ELISA Kit 48T/96T SG-00067 Bovine borrelia burgdorferi (Bb) antibody (IgG) ELISA kit 48T/96T SG-00068 Bovine borrelia burgdorferi (Bb) antibody (IgM) ELISA kit 48T/96T SG-00069 Bovine Brain-derived neurotrophic factor(BDNF) ELISA kit 48T/96T SG-00071 Bovine brucella antibody (IgM) ELISA kit 48T/96T SG-00072 Bovine Brucella antibody( IgG) ELISA kit 48T/96T SG-00073 Bovine Brucella IgG (Brucella-Ab)ELISA Kit 48T/96T SG-00074 Bovine Butyrophilin subfamily 1 member A1(BTN1A1) ELISA kit 48T/96T SG-00075 Bovine Cadherin-1(CDH1) ELISA kit 48T/96T SG-00076 Bovine Calcitonin(CALCA/CALC) ELISA kit 48T/96T SG-00077 Bovine Calpain-1 catalytic subunit(CAPN1) ELISA kit 48T/96T SG-00078 Bovine Calpastatin(CAST) ELISA kit 48T/96T SG-00079 Bovine Calprotectin (CALP) ELISA kit 48T/96T SG-00080 Bovine cardiac troponin I (cTn-I) ELISA kit 48T/96T SG-00081 Bovine Cardiac Troponin T(cTn-T) ELISA kit 48T/96T SG-00082 Bovine casein alpha s1 (CSN1S1) ELISA kit 48T/96T SG-00083 Bovine Caspase 3(Casp-3) ELISA Kit 48T/96T SG-00084 Bovine Caspase 7(Casp-7) ELISA Kit 48T/96T SG-00085 Bovine Caspase 8(Casp-8) ELISA Kit 48T/96T SG-00086 Bovine Caspase 9(Casp-9) ELISA Kit 48T/96T SG-00088 Bovine Catalase (CAT) ELISA kit 48T/96T SG-00089 Bovine C-C motif chemokine 20(CCL20) ELISA kit 48T/96T SG-00090 Bovine C-C motif chemokine 3(CCL3) ELISA kit 48T/96T SG-00091 Bovine C-C motif chemokine 4(CCL4) ELISA kit 48T/96T SG-00092 Bovine C-C motif chemokine 5(CCL5) ELISA kit 48T/96T SG-00093 Bovine C-C motif chemokine 8(CCL8) ELISA kit 48T/96T SG-00094 Bovine CD63 antigen(CD63) ELISA kit 48T/96T SG-00095 Bovine Ceruloplasmin,CP ELISA Kit 48T/96T SG-00096 Bovine Chlamydia abortus ELISA Kit 48T/96T SG-00097 Bovine cholesterol(CH) ELISA Kit 48T/96T SG-00098 Bovine chorionic somatomammotropin hormone (CSH1) ELISA kit 48T/96T SG-00099 Bovine Chorionic somatomammotropin hormone 2(CSH2) ELISA kit 48T/96T SG-00100 Bovine Chromogranin-A(CHGA) ELISA kit 48T/96T SG-00101 Bovine Chymotrypsin-like elastase family member 2A(CELA2A) ELISA kit 48T/96T SG-00102 Bovine Citrulline ELISA KIT 48T/96T SG-00103 Bovine Clusterin(CLU) ELISA kit 48T/96T SG-00104 Bovine Collagen alpha-1(II) chain (COL2A1) ELISA kit 48T/96T SG-00105 Bovine Collagen alpha-1(XVII) chain (COL17A1) ELISA kit 48T/96T SG-00106 Bovine Complement 4(C4) ELISA kit 48T/96T SG-00107 Bovine Complement C1q subcomponent subunit A(C1QA) ELISA kit 48T/96T SG-00108 Bovine Complement C1s subcomponent(C1S) ELISA kit 48T/96T SG-00109 Bovine Complement C2(C2) ELISA kit 48T/96T SG-00110 Bovine Complement C5 (C5) ELISA kit 48T/96T SG-00111 Bovine Complement factor B(CFB) ELISA kit 48T/96T SG-00112 Bovine Complement factor D(CFD) ELISA kit 48T/96T SG-00113 Bovine complement fragment 5a (C5a) ELISA kit 48T/96T SG-00114 Bovine Conglutinin(CGN1) ELISA kit 48T/96T SG-00115 Bovine Corticoliberin(CRH) ELISA kit 48T/96T SG-00116 Bovine Cortisol ELISA kit 48T/96T SG-00117 Bovine coxiella burnetii (Q Fever) ELISA Kit 48T/96T SG-00118 Bovine C-Peptide ELISA Kit 48T/96T SG-00119 Bovine C-reactive protein(CRP)ELISA Kit 48T/96T SG-00120 Bovine Creatine kinase M-type(CKM) ELISA kit 48T/96T SG-00122 Bovine C-telopeptide of type II collagen(CTX-II) ELISA Kit 48T/96T SG-00123 Bovine Cu/Zn-Superoxide Dismutase,Cu/Zn-SOD ELISA Kit 48T/96T SG-00124 Bovine C-X-C motif chemokine 10(CXCL10) ELISA kit 48T/96T SG-00125 Bovine C-X-C motif chemokine 6(CXCL6) ELISA kit 48T/96T SG-00126 Bovine C-X-C motif chemokine 9(CXCL9) ELISA kit 48T/96T SG-00127 Bovine cytokeratin fragment antigen 21-1,CYFRA21-1 ELISA Kit 48T/96T SG-00128 Bovine Cytokine receptor common subunit gamma(IL2RG) ELISA kit 48T/96T SG-00129 Bovine Decorin(DCN) ELISA kit 48T/96T SG-00130 Bovine Defensin Beta 1 (DEFb1) ELISA Kit 48T/96T SG-00131 Bovine Defensin Beta 2 (DEFb2) ELISA Kit 48T/96T SG-00132 Bovine Deoxyribonuclease-1(DNASE1) ELISA kit 48T/96T SG-00133 Bovine Diamine Oxidase (DAO) ELISA Kit 48T/96T SG-00134 Bovine Di-N-acetylchitobiase(CTBS) ELISA kit 48T/96T SG-00135 Bovine Dipeptidyl peptidase 4(DPP4) ELISA kit 48T/96T SG-00136 Bovine Ectonucleoside triphosphate diphosphohydrolase 1(ENTPD1) ELISA kit 48T/96T SG-00137 Bovine elastase 2, neutrophil (ELA2)ELISA kit 48T/96T SG-00139 Bovine Elastin(ELN) ELISA kit 48T/96T SG-00140 Bovine Endothelin-converting enzyme 1(ECE1) ELISA kit 48T/96T SG-00141 Bovine Epithelial growth factor(EGF)ELISA Kit 48T/96T SG-00142 Bovine Erythropoietin(EPO) ELISA kit 48T/96T SG-00143 Bovine Estradiol(E2) ELISA Kit 48T/96T SG-00144 Bovine Fibrinogen,Fb Elisa Kit 48T/96T SG-00145 Bovine fibroblast growth factor 21 (FGF21) ELISA kit 48T/96T SG-00146 Bovine Fibroblast Growth Factor 23 (FGF23) ELISA Kit 48T/96T SG-00147 Bovine fibromodulin,FMOD ELISA Kit 48T/96T SG-00148 Bovine Fibronectin,FN ELISA Kit 48T/96T SG-00149 Bovine folic acid,FA ELISA Kit 48T/96T SG-00150 Bovine follicle-stimulating hormone(FSH)ELISA Kit 48T/96T SG-00151 Bovine Follistatin-related protein 3(FSTL3) ELISA kit 48T/96T SG-00152 Bovine Foot and Mouth Disease Virus(FMDV) antibody ELISA Kit 48T/96T SG-00154 Bovine free thyroxine (FT4) ELISA kit 48T/96T SG-00155 Bovine free tri-iodothyronine (FT3) ELISA kit 48T/96T SG-00156 Bovine fructosamin (FRA) ELISA kit 48T/96T SG-00157 Bovine Galanin(GAL) ELISA kit 48T/96T SG-00158 Bovine Gastric inhibitory polypeptide(GIP) ELISA kit 48T/96T SG-00159 Bovine gastrin (GAST) ELISA kit
Load more

Recommended publications
  • Viewed Under 23 (B) Or 203 (C) fi M M Male Cko Mice, and Largely Unaffected Magni Cation; Scale Bars, 500 M (B) and 50 M (C)
    BRIEF COMMUNICATION www.jasn.org Renal Fanconi Syndrome and Hypophosphatemic Rickets in the Absence of Xenotropic and Polytropic Retroviral Receptor in the Nephron Camille Ansermet,* Matthias B. Moor,* Gabriel Centeno,* Muriel Auberson,* † † ‡ Dorothy Zhang Hu, Roland Baron, Svetlana Nikolaeva,* Barbara Haenzi,* | Natalya Katanaeva,* Ivan Gautschi,* Vladimir Katanaev,*§ Samuel Rotman, Robert Koesters,¶ †† Laurent Schild,* Sylvain Pradervand,** Olivier Bonny,* and Dmitri Firsov* BRIEF COMMUNICATION *Department of Pharmacology and Toxicology and **Genomic Technologies Facility, University of Lausanne, Lausanne, Switzerland; †Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts; ‡Institute of Evolutionary Physiology and Biochemistry, St. Petersburg, Russia; §School of Biomedicine, Far Eastern Federal University, Vladivostok, Russia; |Services of Pathology and ††Nephrology, Department of Medicine, University Hospital of Lausanne, Lausanne, Switzerland; and ¶Université Pierre et Marie Curie, Paris, France ABSTRACT Tight control of extracellular and intracellular inorganic phosphate (Pi) levels is crit- leaves.4 Most recently, Legati et al. have ical to most biochemical and physiologic processes. Urinary Pi is freely filtered at the shown an association between genetic kidney glomerulus and is reabsorbed in the renal tubule by the action of the apical polymorphisms in Xpr1 and primary fa- sodium-dependent phosphate transporters, NaPi-IIa/NaPi-IIc/Pit2. However, the milial brain calcification disorder.5 How- molecular identity of the protein(s) participating in the basolateral Pi efflux remains ever, the role of XPR1 in the maintenance unknown. Evidence has suggested that xenotropic and polytropic retroviral recep- of Pi homeostasis remains unknown. Here, tor 1 (XPR1) might be involved in this process. Here, we show that conditional in- we addressed this issue in mice deficient for activation of Xpr1 in the renal tubule in mice resulted in impaired renal Pi Xpr1 in the nephron.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Steroid-Dependent Regulation of the Oviduct: a Cross-Species Transcriptomal Analysis
    University of Kentucky UKnowledge Theses and Dissertations--Animal and Food Sciences Animal and Food Sciences 2015 Steroid-dependent regulation of the oviduct: A cross-species transcriptomal analysis Katheryn L. Cerny University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Cerny, Katheryn L., "Steroid-dependent regulation of the oviduct: A cross-species transcriptomal analysis" (2015). Theses and Dissertations--Animal and Food Sciences. 49. https://uknowledge.uky.edu/animalsci_etds/49 This Doctoral Dissertation is brought to you for free and open access by the Animal and Food Sciences at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Animal and Food Sciences by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
    Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen,
    [Show full text]
  • The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid
    The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome Annette K. Brenner, Elise Aasebø, Maria Hernandez-Valladares, Frode Selheim, Frode Berven, Ida-Sofie Grønningsæter, Sushma Bartaula-Brevik and Øystein Bruserud Supplementary Material S2 of S31 Table S1. Detailed information about the 68 AML patients included in the study. # of blasts Viability Proliferation Cytokine Viable cells Change in ID Gender Age Etiology FAB Cytogenetics Mutations CD34 Colonies (109/L) (%) 48 h (cpm) secretion (106) 5 weeks phenotype 1 M 42 de novo 241 M2 normal Flt3 pos 31.0 3848 low 0.24 7 yes 2 M 82 MF 12.4 M2 t(9;22) wt pos 81.6 74,686 low 1.43 969 yes 3 F 49 CML/relapse 149 M2 complex n.d. pos 26.2 3472 low 0.08 n.d. no 4 M 33 de novo 62.0 M2 normal wt pos 67.5 6206 low 0.08 6.5 no 5 M 71 relapse 91.0 M4 normal NPM1 pos 63.5 21,331 low 0.17 n.d. yes 6 M 83 de novo 109 M1 n.d. wt pos 19.1 8764 low 1.65 693 no 7 F 77 MDS 26.4 M1 normal wt pos 89.4 53,799 high 3.43 2746 no 8 M 46 de novo 26.9 M1 normal NPM1 n.d. n.d. 3472 low 1.56 n.d. no 9 M 68 MF 50.8 M4 normal D835 pos 69.4 1640 low 0.08 n.d.
    [Show full text]
  • Genome-Wide Sirna Screen for Mediators of NF-Κb Activation
    Genome-wide siRNA screen for mediators SEE COMMENTARY of NF-κB activation Benjamin E. Gewurza, Fadi Towficb,c,1, Jessica C. Marb,d,1, Nicholas P. Shinnersa,1, Kaoru Takasakia, Bo Zhaoa, Ellen D. Cahir-McFarlanda, John Quackenbushe, Ramnik J. Xavierb,c, and Elliott Kieffa,2 aDepartment of Medicine and Microbiology and Molecular Genetics, Channing Laboratory, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; bCenter for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; cProgram in Medical and Population Genetics, The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142; dDepartment of Biostatistics, Harvard School of Public Health, Boston, MA 02115; and eDepartment of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115 Contributed by Elliott Kieff, December 16, 2011 (sent for review October 2, 2011) Although canonical NFκB is frequently critical for cell proliferation, (RIPK1). TRADD engages TNFR-associated factor 2 (TRAF2), survival, or differentiation, NFκB hyperactivation can cause malig- which recruits the ubiquitin (Ub) E2 ligase UBC5 and the E3 nant, inflammatory, or autoimmune disorders. Despite intensive ligases cIAP1 and cIAP2. CIAP1/2 polyubiquitinate RIPK1 and study, mammalian NFκB pathway loss-of-function RNAi analyses TRAF2, which recruit and activate the K63-Ub binding proteins have been limited to specific protein classes. We therefore under- TAB1, TAB2, and TAB3, as well as their associated kinase took a human genome-wide siRNA screen for novel NFκB activa- MAP3K7 (TAK1). TAK1 in turn phosphorylates IKKβ activa- tion pathway components. Using an Epstein Barr virus latent tion loop serines to promote IKK activity (4).
    [Show full text]
  • Expression of SLC2A9 Isoforms in the Kidney and Their Localization in Polarized Epithelial Cells
    Expression of SLC2A9 Isoforms in the Kidney and Their Localization in Polarized Epithelial Cells Toru Kimura1, Michi Takahashi1, Kunimasa Yan2, Hiroyuki Sakurai1* 1 Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan, 2 Department of Pediatrics, Kyorin University School of Medicine, Mitaka, Tokyo, Japan Abstract Background: Many genome-wide association studies pointed out that SLC2A9 gene, which encodes a voltage-driven urate transporter, SLC2A9/GLUT9 (a.k.a. URATv1), as one of the most influential genes for serum urate levels. SLC2A9 is reported to encode two splice variants: SLC2A9-S (512 amino acids) and SLC2A9-L (540 amino acids), only difference being at their N- termini. We investigated isoform-specific localization of SLC2A9 in the human kidney and role of N-terminal amino acids in differential sorting in vitro. Methodology/Principal Findings: Isoform specific antibodies against SLC2A9 were developed and human kidney sections were stained. SLC2A9-S was expressed in the apical side of the collecting duct while SLC2A9-L was expressed in the basolateral side of the proximal tubule. GFP fused SLC2A9s were expressed in MDCK cells and intracellular localization was observed. SLC2A9-S was expressed at both apical and basolateral membranes, whereas SLC2A9-L was expressed only at the basolateral membrane. Although SLC2A9-L has a putative di-leucine motif at 33th and 34th leucine, deletion of the motif or replacement of leucine did not affect its subcellular localization. When up to 16 amino acids were removed from the N- terminal of SLC2A9-S or when up to 25 amino acids were removed from the N-terminal of SLC2A9-L, there was no change in their sorting.
    [Show full text]
  • 2.1 Drosophila Melanogaster
    Overend, Gayle (2010) Drosophila as a model for the Anopheles Malpighian tubule. PhD thesis, University of Glasgow. http://theses.gla.ac.uk/1604/ Copyright and moral rights for this thesis are retained by the author A copy can be downloaded for personal non-commercial research or study, without prior permission or charge This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the Author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the Author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Glasgow Theses Service http://theses.gla.ac.uk/ [email protected] Drosophila as a model for the Anopheles Malpighian tubule A thesis submitted for the degree of Doctor of Philosophy at the University of Glasgow Gayle Overend Integrative and Systems Biology Faculty of Biomedical and Life Sciences University of Glasgow Glasgow G11 6NU UK August 2009 2 The research reported within this thesis is my own work except where otherwise stated, and has not been submitted for any other degree. Gayle Overend 3 Abstract The insect Malpighian tubule is involved in osmoregulation, detoxification and immune function, physiological processes which are essential for insect development and survival. As the Malpighian tubules contain many ion channels and transporters, they could be an effective tissue for targeting with novel pesticides to control populations of Diptera. Many of the insecticide compounds used to control insect pest species are no longer suited to their task, and so new means of control must be found.
    [Show full text]
  • Supplemental Information
    Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig.
    [Show full text]
  • Association of Gene Ontology Categories with Decay Rate for Hepg2 Experiments These Tables Show Details for All Gene Ontology Categories
    Supplementary Table 1: Association of Gene Ontology Categories with Decay Rate for HepG2 Experiments These tables show details for all Gene Ontology categories. Inferences for manual classification scheme shown at the bottom. Those categories used in Figure 1A are highlighted in bold. Standard Deviations are shown in parentheses. P-values less than 1E-20 are indicated with a "0". Rate r (hour^-1) Half-life < 2hr. Decay % GO Number Category Name Probe Sets Group Non-Group Distribution p-value In-Group Non-Group Representation p-value GO:0006350 transcription 1523 0.221 (0.009) 0.127 (0.002) FASTER 0 13.1 (0.4) 4.5 (0.1) OVER 0 GO:0006351 transcription, DNA-dependent 1498 0.220 (0.009) 0.127 (0.002) FASTER 0 13.0 (0.4) 4.5 (0.1) OVER 0 GO:0006355 regulation of transcription, DNA-dependent 1163 0.230 (0.011) 0.128 (0.002) FASTER 5.00E-21 14.2 (0.5) 4.6 (0.1) OVER 0 GO:0006366 transcription from Pol II promoter 845 0.225 (0.012) 0.130 (0.002) FASTER 1.88E-14 13.0 (0.5) 4.8 (0.1) OVER 0 GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolism3004 0.173 (0.006) 0.127 (0.002) FASTER 1.28E-12 8.4 (0.2) 4.5 (0.1) OVER 0 GO:0006357 regulation of transcription from Pol II promoter 487 0.231 (0.016) 0.132 (0.002) FASTER 6.05E-10 13.5 (0.6) 4.9 (0.1) OVER 0 GO:0008283 cell proliferation 625 0.189 (0.014) 0.132 (0.002) FASTER 1.95E-05 10.1 (0.6) 5.0 (0.1) OVER 1.50E-20 GO:0006513 monoubiquitination 36 0.305 (0.049) 0.134 (0.002) FASTER 2.69E-04 25.4 (4.4) 5.1 (0.1) OVER 2.04E-06 GO:0007050 cell cycle arrest 57 0.311 (0.054) 0.133 (0.002)
    [Show full text]
  • 9-Azido Analogs of Three Sialic Acid Forms for Metabolic Remodeling Of
    Supporting Information 9-Azido Analogs of Three Sialic Acid Forms for Metabolic Remodeling of Cell-Surface Sialoglycans Bo Cheng,†,‡ Lu Dong,†,§ Yuntao Zhu,†,‡ Rongbing Huang,†,‡ Yuting Sun,†,‖ Qiancheng You,†,‡ Qitao Song,†,§ James C. Paton, ∇ Adrienne W. Paton,∇ and Xing Chen*,†,‡,§,⊥,# †College of Chemistry and Molecular Engineering, ‡Beijing National Laboratory for Molecular Sciences, §Peking−Tsinghua Center for Life Sciences,‖Academy for Advanced Interdisciplinary Studies, ⊥Synthetic and Functional Biomolecules Center, and #Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Peking University, Beijing 100871, China ∇Research Centre for Infectious Diseases, Department of Molecular and Biomedical Science, University of Adelaide, Adelaide SA 5005, Australia Page S1 Table of Contents: Scheme S1.……………………………………………………….........……………. S3 Figure S1……………………………………………………..………..……………. S3 Figure S2……………………………………………………..………..…………… S4 Figure S3……………………………………………………..………..…………… S4 Figure S4……………………………………………………..………..…………… S5 Figure S5……………………………………………………..………..…………… S6 Figure S6……………………………………………………..………..…………….S7 Figure S7……………………………………………………..………..…………….S8 Figure S8……………………………………………………..………..…………….S9 Experimental Procedures……………………………….…........…………....S10-S27 Table S1………………………………………………..………..…………….S28-S48 Supporting Reference……………………………………………….......………...S49 Page S2 Scheme S1. Synthesis of 9AzNeu5Gc Figure S1: a, b, c, d) Representative scatter plots (FSC vs. SSC) and histograms of flow cytometry analysis
    [Show full text]
  • Investigation of the Underlying Hub Genes and Molexular Pathogensis in Gastric Cancer by Integrated Bioinformatic Analyses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Investigation of the underlying hub genes and molexular pathogensis in gastric cancer by integrated bioinformatic analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The high mortality rate of gastric cancer (GC) is in part due to the absence of initial disclosure of its biomarkers. The recognition of important genes associated in GC is therefore recommended to advance clinical prognosis, diagnosis and and treatment outcomes. The current investigation used the microarray dataset GSE113255 RNA seq data from the Gene Expression Omnibus database to diagnose differentially expressed genes (DEGs). Pathway and gene ontology enrichment analyses were performed, and a proteinprotein interaction network, modules, target genes - miRNA regulatory network and target genes - TF regulatory network were constructed and analyzed. Finally, validation of hub genes was performed. The 1008 DEGs identified consisted of 505 up regulated genes and 503 down regulated genes.
    [Show full text]